Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism.

Literature DB >> 26607705

Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism.

Emma Guttman-Yassky¹, Benjamin Ungar², Shinji Noda³, Maria Suprun⁴, Anjali Shroff⁵, Riana Dutt⁵, Saakshi Khattri⁵, Michelle Min⁵, Yasaman Mansouri⁵, Xiuzhong Zheng³, Yeriel D Estrada⁵, Giselle K Singer⁵, Mayte Suarez-Farinas⁶, James G Krueger³, Mark G Lebwohl⁵.

Abstract

Mesh：

Substances：

Year: 2015 PMID： 26607705 DOI： 10.1016/j.jaci.2015.11.001

Source DB: PubMed Journal: J Allergy Clin Immunol ISSN： 0091-6749 Impact factor: 10.793

Keyword Cloud
Cited

× No keyword cloud information.

22 in total

1. IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans.

Authors: Luana S Ortolan; Sa Rang Kim; Sydney Crotts; Lucy Y Liu; Brittany G Craiglow; Carlos Wambier; Renato S Paschoal; Brett A King; Ali Jabbari
Journal: J Allergy Clin Immunol Date: 2019-08-27 Impact factor: 10.793

2. Incident alopecia areata and vitiligo in adult women with atopic dermatitis: Nurses' Health Study 2.

Authors: A M Drucker; J M Thompson; W-Q Li; E Cho; T Li; E Guttman-Yassky; A A Qureshi
Journal: Allergy Date: 2017-02-06 Impact factor: 13.146

Review 3. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.

Authors: Patrick M Brunner; Emma Guttman-Yassky; Donald Y M Leung
Journal: J Allergy Clin Immunol Date: 2017-04 Impact factor: 10.793

Review 4. Alopecia areata.

Authors: C Herbert Pratt; Lloyd E King; Andrew G Messenger; Angela M Christiano; John P Sundberg
Journal: Nat Rev Dis Primers Date: 2017-03-16 Impact factor: 52.329

Review 5. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.

Authors: Cheng Zhou; Xiangqian Li; Chen Wang; Jianzhong Zhang
Journal: Clin Rev Allergy Immunol Date: 2021-08-17 Impact factor: 8.667

Review 6. Understanding autoimmunity of vitiligo and alopecia areata.

Authors: Jillian F Rork; Mehdi Rashighi; John E Harris
Journal: Curr Opin Pediatr Date: 2016-08 Impact factor: 2.856

7. Prostaglandin E₂ stimulates adaptive IL-22 production and promotes allergic contact dermatitis.

Authors: Calum T Robb; Henry J McSorley; Jinju Lee; Tomohiro Aoki; Cunjing Yu; Siobhan Crittenden; Anne Astier; Jennifer M Felton; Nicholas Parkinson; Adane Ayele; Richard M Breyer; Stephen M Anderton; Shuh Narumiya; Adriano G Rossi; Sarah E Howie; Emma Guttman-Yassky; Richard B Weller; Chengcan Yao
Journal: J Allergy Clin Immunol Date: 2017-06-03 Impact factor: 10.793

Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism.

1. IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans.

2. Incident alopecia areata and vitiligo in adult women with atopic dermatitis: Nurses' Health Study 2.

Review 3. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.

Review 4. Alopecia areata.

Review 5. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.

Review 6. Understanding autoimmunity of vitiligo and alopecia areata.

7. Prostaglandin E₂ stimulates adaptive IL-22 production and promotes allergic contact dermatitis.

Review 8. New and Emerging Therapies for Alopecia Areata.

Review 9. Treatment of pediatric alopecia areata: A systematic review.

Review 10. Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.

Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism.

1. IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans.

2. Incident alopecia areata and vitiligo in adult women with atopic dermatitis: Nurses' Health Study 2.

Review 3. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.

Review 4. Alopecia areata.

Review 5. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.

Review 6. Understanding autoimmunity of vitiligo and alopecia areata.

7. Prostaglandin E2 stimulates adaptive IL-22 production and promotes allergic contact dermatitis.

Review 8. New and Emerging Therapies for Alopecia Areata.

Review 9. Treatment of pediatric alopecia areata: A systematic review.

Review 10. Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.

7. Prostaglandin E₂ stimulates adaptive IL-22 production and promotes allergic contact dermatitis.